# Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection

> **NCT02095444** · PHASE1,PHASE2 · UNKNOWN · sponsor: **S-Evans Biosciences Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Acute Lung Injury
- Acute Respiratory Distress Syndrome (ARDS)
- Multiple Organ Failure

## Interventions

- **DRUG:** Menstrual blood stem cells

## Key facts

- **NCT ID:** NCT02095444
- **Lead sponsor:** S-Evans Biosciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02095444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02095444, "Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02095444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*